NCT02918630View on ClinicalTrials.gov

E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Tobacco Smoking
Interventions
DRUG

Nicotine Patch

Participants will receive nicotine patch (21 mg) starting study Week 1. Participants will be instructed to apply a new patch each morning.

DRUG

E-cigarette

The e-cigarette will consist of 1) a 3.3 V, 1000 mAh battery; and 2) a 1.5 Ohm, dual-coil cartomizer (SmokTech; Shenzhen, China). Study staff will load the cartomizer with 1 ml tobacco flavored 70% propylene glycol/30% vegetable glycerin liquid containing nicotine concentrations 36 mg/ml (AVAIL; Richmond, Virginia, USA).

Trial Locations (1)

77054

University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02918630 - E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia | Biotech Hunter | Biotech Hunter